Anton H.
- Country
- Austria
- Department
- Department of Ophthalmology
Research Overview
- Phase III Randomized Double‑Masked Sham‑Controlled Trial of Intravitreal IL6‑Mab in Patients with Uveitic Macular Edema
- Efficacy of dual 8 mg aflibercept loading doses in treatment-naive patients with neovascular age-related macular degeneration
- Evaluation of Ranibizumab Port Delivery System Refill Regimens in Neovascular Age-Related Macular Degeneration: A Phase IIIb Randomized Study
Data & Insights
Has run more than one trial at 72 of 167 partner sites.
Specializations
Macular Disorders
This investigator specializes in treating neovascular age-related macular degeneration (nAMD), exploring innovative delivery systems for therapeutic agents. Their research encompasses long-term management approaches and novel treatment methods for maintaining visual acuity in affected patients.
- Port Delivery System Technology
- Extended-duration Treatment Protocols
- Visual Acuity Maintenance Strategies
The investigator focuses on evaluating sustained-release drug delivery systems to improve treatment outcomes for macular disorders.
Inflammatory Eye Conditions
The investigator conducts research in non-infectious uveitis and its variants, including intermediate, posterior, and pan-uveitis. Their work extends to studying novel therapeutic approaches for uveitic macular edema.
- Uveitis Management
- Macular Edema Treatment
- Anti-inflammatory Therapies
Their research explores intravitreal treatments and biological therapies for inflammatory eye conditions.
Thyroid-Related Ophthalmology
The investigator studies treatments for moderate-to-severe thyroid eye disease, with particular attention to reducing proptosis through innovative biological therapies.
- Proptosis Management
- Subcutaneous Treatments
- Therapeutic Response Assessment
Their work focuses on evaluating novel therapeutic agents for thyroid-related eye conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.